Fate Therapeutics reports 2023 annual meeting voting results

FATE THERAPEUTICS INC

Elected Class I directors Epstein, Mendlein, Jooss with >65.8M 'for' votes each; 10.2M broker non-votes.
Ratified Ernst & Young as auditor for FY2023: 85.5M for, 0.2M against, 1.2M abstentions.
Approved non-binding advisory vote on executive compensation: 73.7M for, 3.0M against, 0.1M abstentions.
Total shares present at meeting: 86.9M of 98.2M outstanding.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

FATE THERAPEUTICS INC shareholders approved Non-binding advisory vote to approve compensation of named executive officers at the 2023-06-06 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-06-06

Exact text from the filing

Non-binding Advisory Vote on Compensation of Named Executive Officers. For Against Abstain Broker Non-Votes 73,720,442 2,955,503 61,938 10,211,752

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

FATE THERAPEUTICS INC shareholders approved Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm at the 2023-06-06 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-06

Exact text from the filing

Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. For Against Abstain Broker Non-Votes 85,534,350 197,464 1,217,821 —

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

FATE THERAPEUTICS INC shareholders approved Election of three Class I Directors at the 2023-06-06 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-06

Exact text from the filing

Election of Class I Directors. Director Nominee For Withheld Broker Non-Votes Robert S. Epstein, M.D., M.S. 74,088,457 2,649,426 10,211,752 John D. Mendlein, Ph.D., J.D. 65,801,671 10,936,212 10,211,752 Karin Jooss, Ph.D. 74,481,093 2,256,790 10,211,752

View on SEC.gov

545 shareholder votes filed in the last 30 days. Browse all shareholder votes →

FATE THERAPEUTICS INC filing history →

Source: SEC EDGAR

accession 0000950170-23-027262

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.